-/-mice exposed to acute and chronic DSS showed a significant decrease in the clinical parameters and in colonic expression of pro-inflammatory cytokines compared with WT mice. mRNA expression of antioxidant enzymes in colon samples was significantly increased in Prdx6 -/-compared with WT mice exposed to acute and chronic DSS. In addition, total GSH levels were increased in Prdx6 -/-mice treated with DSS in comparison with WT. Overexpression of Prdx6 did not significantly influence acute and chronic colitis. Conclusions: Our data indicate that a lack of the antioxidant enzyme PRDX6 protects against the development of acute and chronic experimental colitis and is associated with increased expression and function of other antioxidant enzymes, suggesting effective compensatory mechanisms.
Introduction
The major forms of inflammatory bowel diseases [ The mechanisms by which imbalances of the immune system initiate and perpetuate intestinal damage and inflammation are not entirely clear. However, inflammatory conditions lead to an increased oxidative burden due to the release of reactive oxygen species [ROS] by activated macrophages and neutrophils as a part of the body's defence mechanisms. 4 Low levels of ROS have a protective effect by activating protective signalling pathways against inflammation and by modulating the immune-mediated attack against extrinsic pathogens. Conversely, high levels of ROS create oxidative stress within the cells and, in case of chronic exposure, changes in the genome such as single strand DNA breaks, sugar moiety modifications and deamination and adduction of bases 5 leading to a loss of homeostasis. 6 Several studies have established a direct relation between oxidative stress and IBD pathogenesis both in human subjects and in animals subjected to experimental colitis. Clinical studies showed an increase of ROS as well as biomarkers of oxidative injury, including lipid peroxidation products and protein modifications, in the intestinal mucosa of patients with either UC or CD. 7, 8 These highly cytotoxic molecules contribute to tissue damage in IBD. 9 In line with this, Barbosa et al. 10 showed a correlation between the activity of free radicals in the intestinal mucosa of IBD patients, and the clinical disease activity. To maintain adequate ROS levels, a balance between oxidant and antioxidant mechanisms is necessary. A depletion of antioxidant levels in the intestinal mucosa and in peripheral red blood cells has been observed in IBD patients. [11] [12] [13] Genetic polymorphisms in antioxidant enzymes are associated with altered enzyme activity and a higher risk of developing IBD.
14 In animal models of IBD, multiple studies demonstrated an increased formation of ROS in the colonic mucosa. 15, 16 In line with this, experimental colitis is associated with a decrease in the levels of endogenous antioxidants in colonic tissue. 17 Genetic deletion of ROS-detoxifying enzymes increases the susceptibility towards tissue destruction, 18 whereas an overexpression of antioxidant enzymes resulted in attenuation of colitis in mice. 19, 20 Among the most important antioxidant proteins is the peroxiredoxin [PRDX] family. PRDX6, a bifunctional 25-kDa protein, is the only member of PRDXs that confers both glutathione [GSH] peroxidase and phospholipase A 2 activities. 21 Despite intensive investigations, the role of PRDX6 in inflammation is still controversial. PRDX6 has both protective [as in experimental autoimmune encephalomyelitis, 22 UV light exposure, 23 wound healing in the skin 24 and hepatocellular injury in an ischaemia-reperfusion model 25 ] and deleterious effects [e.g. higher loss of dopaminergic neurons in a model of Parkinsons disease 26 ]. In order to elucidate the impact of PRDX6 in intestinal inflammation and for the first time address its role in IBD, we induced acute and chronic colitis in Prdx6-deficient or -overexpressing mice.
Materials and Methods

Patients
Colon and ileum samples from IBD patients and controls were obtained by colonoscopy as described previously. 27 
Animals
Induction of acute and chronic DSS-induced colitis
Female mice received 2% DSS [MW 36 000-50 000, MP Biomedicals, Santa Ana, USA] in drinking water for 7 days for induction of acute DSS colitis and five 7-day cycles of 2% DSS interspaced with 10-day recovery phases with normal drinking water for induction of chronic DSS colitis. After the last DSS cycle, animals were kept on normal drinking water for another 4 weeks to investigate the then established chronic intestinal inflammation. During induction of colitis, clinical symptoms were recorded daily [weight change, animal appearance, stool appearance]. At the end of the experiment [Day 7 or 105], colitis severity was assessed by endoscopy and tissues samples were collected. Results represent two independent experiments with a total of n = 12 per group. Endoscopic score was evaluated according to a scoring system (murine endoscopic index of colitis severity [MEICS]) as described previously. 32 
Endoscopic assessment and scoring
Histological assessment and scoring
Histological assessment was performed on 5-μM-thick sections of the distal colon, stained with haematoxylin and eosin [H&E] . Histological score was assessed by two independent blinded investigators as described previously. 3 Epithelium [E] was scored as 0: normal morphology; 1: loss of goblet cells; 2: loss of goblet cells in large areas; 3: loss of crypts; 4: loss of crypts in large areas. Infiltration [I] was scored as 0: no infiltrate; 1: infiltrate around crypt bases; 2: infiltrate reaching to L. muscularis mucosae; 3: extensive infiltration reaching the L. muscularis mucosae and thickening of the mucosa with abundant oedema; 4: infiltration of the L. submucosa. The total histological score represents the sum of the epithelium and infiltration scores in the distal and in the proximal colon, and thus ranges from 0 to 16: (total score = [E + I] distal + [E + I] proximal ). 
Myeloperoxidase activity
. Amplifications were performed in triplicate, and data were normalized to VIL1 levels in human biopsies and to Actb1 levels in murine samples.
Immunoblotting
Total protein was extracted from the colon by lysing homogenized tissue in RIPA buffer [0.5% sodium deoxycholate, 0.1% SDS, 1% NP-40] supplemented with protease inhibitors [Roche Diagnostics, Mannheim, Germany] and quantified using the BCA method. For each group, a total of 30 µg of protein was transferred to a nitrocellulose membrane after electrophoretic separation. The membrane was prehybridized in 5 g/l skim milk or BSA for 1 h. The nitrocellulose membrane was then incubated overnight with PRDX3, PRDX4, PRDX6, NRF2, GSS, GCLM and GCLC primary antibody. After washing in TBS, the appropriate secondary antibody conjugated to HRP was added, and the membrane was incubated at ambient temperature for 1 h. After washing in TBST again, the proteins were visualized using an ECL or ECL PLUS detection kit [Amersham, Velizy-Villacoublay, France]. β-ACTIN was used as an internal reference control.
Determination of glutathione content
Total glutathione (GSH and reduced glutathione disulphide [GSSG]) levels were determined according to a modification of the Tietze recycling assay as described by Rahman et al. 34 In brief, deproteinized cytosolic extracts of tissue samples were obtained by mechanical homogenization in extraction buffer [0.1% Triton X-100 and 0.6% sulphosalicylic acid in 0.1 M potassium phosphate buffer with 5 mM EDTA disodium salt, pH 7.5]. After centrifugation at 2000 rpm for 5 min at 4°C, the resultant supernatant was added to 120 µl of DTNB and glutathione reductase solution; After 30 s, 30 µl of β-NADPH was added. The absorbance of supernatant was measured at 412 nm against a reagent blank. The amount of GSH was expressed as µM/mg protein.
Statistical analysis
Statistical analysis was performed with the statistical software package SPSS Version 22 using the Mann-Whitney rank sum test for non-parametrically distributed samples. Differences were considered significant at p < 0.05 [*], highly significant at p < 0.01 [**], and very highly significant at p < 0.001 [***].
Results
Prdx6
-/-mice are more resistant to DSS-induced acute and chronic colitis
To characterize the function of PRDX6 during intestinal inflammation, WT and Prdx6 -/-mice at 8 weeks of age were administered 2% DSS in their drinking water for 7 days to induce inflammation in the large intestine. Colitis was characterized by weight loss, bloody diarrhoea and inflammatory cell infiltration, as previously described. 35 On challenge with DSS, the onset of weight loss occurred earlier in WT mice, with 10.3 +/-1.4% weight loss in WT mice on Day 6 in contrast to 5.4 +/-1.5% weight loss in Prdx6 -/-mice [p = 0.0336; Figure 1A ]. Further, on Day 7 WT mice displayed significantly more severe body weight loss in comparison with Prdx6 -/-mice [WT 11.7 +/-1.3% vs 6.3 +/-1.7% in Prdx6 -/-; p = 0.0315; Figure 1A ]. Consistently, at autopsy WT DSS mice showed more pronounced shortening of the large intestine in comparison with Prdx6 -/-DSS mice [6.3 cm vs 7.9 cm; p < 0.0001; Figure 1B ]. The reduced susceptibility of Prdx6 -/-mice to acute DSS-induced colitis was confirmed when analysing further parameters indicative of intestinal inflammation: MPO activity was lower in colon samples from the Prdx6 -/-DSS group in comparison with the WT DSS group [145.5 U vs 742.5 U; p < 0.0001; Figure 1C ], and the colonoscopy score was lower in Prdx6 -/-DSS mice in comparison with the WT DSS group [5.1 vs 2; p = 0.0049; Figure 1D ]. Histological analysis of H&E-stained colon tissue sections from WT DSS mice showed significantly more mucosal damage, loss of goblet cells and inflammatory cell infiltrate than Prdx6 -/-DSS mice [12.1 vs 5.9; p < 0.0001; Figure 1E ].
In contrast to the marked protection from body weight loss in Prdx6 -/-mice during acute colitis, no difference was found for body -/-DSS group [6.5 vs 3.6; p = 0.0230; Figure 2D ]. Consistently, histological analysis demonstrated more severe inflammation in WT than in Prdx6 -/-mice: more mucosal damage, loss of goblet cells and inflammatory cell infiltration were observed in WT mice with an average score of 12.8 in WT vs 8.7 in Prdx6 -/-mice [p = 0.0236; Figure 2E ]. Taken together, our results demonstrate that genetic ablation of Prdx6 renders mice less susceptible to DSS-induced acute and chronic colitis.
Loss of Prdx6 decreases the expression of pro-inflammatory cytokines in DSS-induced acute and chronic colitis
To further study the impact of loss of Prdx6 on intestinal inflammation, the expression of mRNAs coding for tumour necrosis factor Figure 1F ]. Consistently, in DSS-induced chronic colitis there was a significant pdecrease in the expression level of Tnfa (7- Figure 2F ].
DSS mice in comparison with WT DSS animals [
Prdx6 is downregulated in murine experimental colitis but overexpressed in human colonic biopsies of IBD patients
To study how endogenous Prdx6 expression is regulated during colitis, we determined PRDX6 protein expression by western blotting. Both wild type and Prdx6 tg/tg animals show significant downregulation of PRDX6 in the acute DSS colitis model [p = 0.0001 and p = 0.0136, respectively, Figure 3A , B]. A similar downregulation was observed in the chronic model [data not shown]. We further analysed the mRNA expression of PRDX6 in colonic and ileal biopsies of IBD patients and controls. Interestingly, we observed a significant increase in PRDX6 mRNA levels in colonic biopsies taken from affected tissue of IBD patients [ Figure 3C ], whereas ileal biopsies showed a tendency towards downregulation of Prdx6 [ Figure 3D ]. Figure 4C ]. In colonic mucosa of mice exposed to chronic DSS, the expression level of Prdx3 [2.3- Figure 4D ].
Loss of
To study functional consequences of altered Gss and Gclm mRNA expression, we determined total GSH levels in colon homogenates of WT and Prdx6 -/-mice exposed to DSS. In both the acute and the chronic DSS models, total GSH levels were increased in Prdx6 -/-mice in comparison with the WT DSS group [2.47-fold, p = 0.0246 and 1.87-fold, p = 0.0001, respectively; Figure 4E and F].
Increased expression of peroxiredoxins and Nrf2 in LPMC but not in IEC
To determine which cellular compartment was responsible for protection in Prdx6 knockout mice, we evaluated the mRNA expression level of antioxidant enzymes [Prdx3, Prdx4, Nrf2, Gss and Gclm] in epithelial cells and in lamina propria mononuclear cells isolated from Prdx6 -/-and WT mice exposed to acute DSS colitis. No differences were observed in the expression levels of these antioxidant enzymes in epithelial cells [ Figure 5A ]. However, we saw significant increases in the mRNA expression levels of Prdx3 ] expressing the Prdx6 sequence of the 129X1/SvJ mouse strain, and subjected them to acute and chronic DSS colitis. The 129X1/SvJ sequence contains an amino acid variant at position 124 encoding for aspartic acid instead of alanine, leading to moderate overexpression of Prdx6. 30 At Day 7 of acute DSS treatment, animals were euthanized and body weight and colon length were measured. No differences in these parameters were found between Prdx6 tg/tg and WT mice treated with DSS [ Figure 6A , and B]. Consistently, MPO activity, endoscopic score and histological score did not differ between Prdx6 tg/tg DSS and WT DSS animals [ Figure 6C -E]. Likewise, we found no differences between Prdx6 tg/tg and WT mice in the chronic DSS colitis model: body weight loss [ Figure 7A ], colon length [ Figure 7B ] and MPO activity [ Figure 7C ] did not show any significant difference between Prdx6 tg/tg DSS and WT DSS animals. Consistently, endoscopic [ Figure 7D ] and histological [ Figure 7E ] evaluation did not show any difference between Prdx6 tg/tg DSS and WT DSS mice.
Cytokine expression in the colon differs in acute and chronic colitis
To study the effect of Prdx6 overexpression on intestinal inflammation, mRNA expression of pro-inflammatory mediators [TNF-α, Overall, our findings show that although loss of Prdx6 protected from DSS-induced colitis, Prdx6 overexpression does not aggravate intestinal inflammation. In the chronic colitis model even lower expression of pro-inflammatory cytokines can be observed.
Levels of peroxiredoxins and antioxidant enzymes in colons of WT and Prdxg tg/tg mice exposed to chronic DSS
Our results suggested that Prdx6 overexpression did not influence the severity of DSS-induced acute and chronic acoltis. However in the chronic model, we saw a significant decrease in the expression level of TNFα and IFNγ. We therefore sought to investigate whether the overexpression of Prdx6 in the chronic model is associated with increased expression of other peroxiredoxins and antioxidant enzymes. For this purpose, we analysed the mRNA expression of Prdx3, Prdx4, Nrf2, Gss and Gclm in WT and Prdx6 tg/tg mice exposed to chronic DSS treatment. The results showed a significant increase in mRNA expression of Prdx3 
Discussion
As an antioxidant enzyme, PRDX6 controls the reactive oxygen species [ROS] level within cells. 36 Intestinal inflammation is accompanied by massive ROS production by activated macrophages and neutrophils, which contributes to inflammation-associated tissue destruction. 4 Hence, antioxidant enzymes might play an important role during intestinal inflammation. We therefore hypothesized that knockout of Prdx6 would lead to enhanced susceptibility to DSS-induced acute and chronic intestinal inflammation, whereas overexpression of Prdx6 would protect against DSS-induced colitis. Surprisingly, our results showed that genetic ablation of Prdx6 healthy control n = 8, CD non-inflamed n = 15, CD inflamed n = 18, CD remission n = 5, UC non-inflamed n = 20, UC inflamed n = 18, UC remission n = 2; ileum: healthy control n = 13, CD non-inflamed n = 6, CD inflamed n = 4, CD remission n = 3, UC non-inflamed n = 4, UC inflamed n = 1, UC remission n = 2. DSS, dextran sodium sulphate; IBD, inflammatory bowel disease; RT-qPCR, real-time quantitative polymerase chain reaction; SEM, standard error of the mean; UC, ulcerative colitis; CD, Crohn's disease.
did not aggravate inflammation, but in contrast protected animals from DSS-induced acute and chronic colitis. On challenge with DSS, Prdx6 -/-mice, in comparison with WT, showed significantly less inflammation as indicated by clinical parameters and mRNA levels of pro-inflammatory cytokines. Lower inflammation was accompanied by an increase in mRNA expression of antioxidant enzymes such as Prdx3, Prdx4, Nrf2, Gss and Gclm. Consistently, total GSH levels were increased in Prdx6-deficient mice in comparison with WT mice. Taken together, this study shows that targeted disruption of Prdx6 ameliorates colitis, associated with an increase in expression of other antioxidant enzymes and a rise in GSH levels suggesting effective compensatory mechanisms.
Increased neutrophil infiltration in the colon is one of the hallmarks of pathophysiology in IBD and in the model of DSS-induced experimental colitis. MPO is predominantly expressed by neutrophils; thus assessment of MPO activity serves as a useful biomarker for neutrophil infiltration. Our results showed that DSS administration, as expected, increased colonic MPO activity, indicating a significant rise in neutrophil infiltration in the DSS colitis models in WT animals. Surprisingly, our data showed a significantly lower increase in MPO activity in Prdx6 -/-mice exposed to both acute and chronic DSS administration in comparison with WT animals. This lower neutrophil infiltration in Prdx6 -/-animals might even be accompanied by lower ROS production, as loss of Prdx6 has been show to impair nicotinamide adenine dinucleotide phosphate [NADPH] oxidase activity. 37 In line with the observed differences in neutrophil infiltration, higher MEICS and histological scores indicated severe tissue damage in WT DSS animals whereas Prdx6 -/-DSS animals showed significantly lower scores.
In IBD, pro-inflammatory cytokines play an important role in the development and progression of the intestinal immune response. Accumulating data on animal models and human studies show an increase in inflammatory cytokines, in particular TNF-α, and a direct relationship between cytokine expression and extent of inflammation. TNF-α activates neutrophils and macrophages, in addition to its induction of IFN-γ production. In this study, on challenge with DSS, the mRNA expression of TNF-α, IFN-γ, Il-6 and IL1β was decreased in Prdx6 -/-mice. Nitric oxide [NO], a key biomarker of oxidative stress, is which is thought to be the main producer of NO in IBD. 38 During inflammation, iNOS is activated and it is induced by cytokines including TNF-α, and IFN-γ. Our results showed a significant decrease in the mRNA expression level of iNOS in Prdx6 -/-mice exposed to acute and chronic DSS. Taken together, our results showed that genetic ablation of Prdx6 conferred protection against DSS-induced acute and chronic colitis.
As lack of Prdx6 had a beneficial effect in the investigated DSS colitis models, we next studied regulation of endogenous Prdx6 protein expression upon induction of colitis. In the acute as well as the chronic DSS model, wildtype and Prdx6 tg/tg animals showed a significant downregulation of PRDX6 in line with the downregulation of PRDX6 in the acute DSS colitis model reported by Naito et al. 39 These findings suggest that no PRDX6 expression is beneficial during intestinal inflammation, as downregulation of Prdx6 seems to be a physiological response in murine colitis models.
In human biopsies the results are more complex. In contrast to the murine data, colonic samples showed significant upregulation of PRDX6 mRNA levels in areas affected by IBD. Ileal samples, on the other hand, showed a non-significant downregulation of PRDX6 mRNA expression in IBD-affected tissue, similar to the regulation observed in murine samples. Previously, increased expression of PRDX6 particularly in epithelial cells of ileal samples of CD patients has been observed. 40 These findings suggest that more detailed studies investigating the regulation of Prdx6 at different stages of inflammation and in different areas of the intestine are necessary to clarify the role of Prdx6 in human IBD.
To address whether downregulation or lack of Prdx6 during colitis acts beneficially by allowing for compensatory upregulation of other peroxiredoxins, we determined the mRNA levels of three other 2-Cys peroxiredoxins [Prdx3, Prdx4 and Prdx5] in colon samples of Prdx6 -/-and WT mice exposed to acute and chronic DSS. To date there is no report describing the role of Prdx3 and Prdx4 in IBD; however, accumulating data indicate a protective role of these antioxidant enzymes in inflammation. Li et al. 41 showed that intratracheal instillation of LPS triggered higher ROS levels in macrophages and more oxidative damage to DNA and proteins in Prdx3 KO mice compared with control animals. Prdx4 was shown to protect against non-alcoholic steatohepatitis, type 2 diabetes mellitus and the metabolic syndrome by reducing oxidative stress-induced injuries. 42 In this study, the mRNA expression levels of Prdx3 and Prdx4 were significantly increased in Prdx6 -/-mice in comparison with WT mice. It is therefore very likely that the increased mRNA levels of Prdx3 and Prdx4 in the colon might compensate for the lack of Prdx6 and lead to enhanced antioxidant defence against DSS-induced oxidative stress in the absence of Prdx6. In line with our results, two previous reports found an increase of Prdx3 and Prdx4 in Prdx6 -/-mice in a hepatic ischaemia/re-perfusion injury model and in cigarette smoke-mediated lung inflammatory response. 25, 43 Taken together, the increase of Prdx3 and Prdx4 in the colon of Prdx6 -/-mice suggests a compensatory response by other Prdx enzymes in response to acute and chronic DSS exposure.
Nuclear factor [erythroid-derived 2]-like 2 [NRF2] is a redoxsensitive transcription factor orchestrating key cellular antioxidant response mechanisms. It activates a wide variety of genes encoding cytoprotective phase II detoxification and antioxidant enzymes such as glutathione synthetase [GSS] and glutamate-cysteine ligase [GCL] 44-47 via the antioxidant-responsive element promoter. 44, 48 It has been documented that the lack of NRF2 leads to a higher susceptibility to DSS-induced colitis 49 and azoxymethane/DSS colitis-associated colorectal carcinoma. 50 Additionally, several studies showed that the application of NRF2-activating substances ameliorated DSS-induced acute colitis. 51, 52 In this study, the mRNA expression of Nrf2, Gclm and Gss was increased in Prdx6 -/-animals exposed to DSS. NRF2 can affect synthesis of glutathione [GSH] , one of the most critical cellular antioxidants, by increasing the expression of Gclc and Gclm subunits and Gss. 53, 54 GSH is associated with reduced inflammation, 55 inhibition of tumour cell growth 56 and prevention of apoptosis. 57 As shown in our study, total GSH levels were increased in Prdx6 -/-mice exposed to acute and chronic DSS. These results are in line with two others reports showing that in Prdx6 -/-mice, the expression level of Nrf2 and the total level of GSH were increased in ethanol-mediated oxidative stress in liver and in cigarette smoke-mediated lung inflammatory response and injury models. 43, 58 Taken together, it appears that a lack of Prdx6 leads to the activation of other antioxidant defence mechanisms that compensate and even overcompensate for the loss of Prdx6 during DSSmediated intestinal inflammation.
Although loss of Prdx6 had significant anti-inflammatory effects in DSS-induced colitis, its overexpression did not affect colitis severity. Due to the protective effects of Prdx6 deletion, one might expect enhanced colitis upon Prdx6 overexpression. However, the protective effect upon loss of Prdx6 seems to be due to compensatory mechanisms and seems to require enhanced expression of other peroxiredoxins. This might explain why an overexpression of Prdx6 does not have the opposite effect on colitis severity compared with Prdx6 deletion, in particular as we observed a likewise induction of Prdx3, Gss and Nrf2. The mechanisms as to how both loss and overexpression of Prdx6 lead to increased expression of other peroxiredoxins and antioxidant enzymes will need to be investigated in further studies. In summary, the results of our study show, for the first time, that genetic ablation of Prdx6 does not aggravate acute and chronic intestinal inflammation but is associated with increased expression of other peroxiredoxins and antioxidant enzymes/molecules, in particular Nrf2 and its target genes Gss, Gclm and GSH. Our findings suggest that maintenance of cellular redox balance during DSS-induced acute and chronic intestinal inflammation by particular peroxiredoxins and antioxidant enzymes is critical. Downregulation of Prdx6 and compensatory upregulation of Prdx3, Prdx4, Nrf2 and enzymes of the GSH pathway seem to be a physiological response during experimental DSS colitis. 
